HYDERABAD, India, June 27, 2016 /PRNewswire/ --
Hetero, one of India's leading genericpharmaceutical companies, today announces the launch of Biosimilar 'Bevacizumab' in India for the treatment of metastatic colorectal cancer (mCRC) under the brand name 'CizumabTM'
The product has been
Commenting on the launch of the product, Dr BPS Reddy, CMD, Hetero Group of Companies said, "It has been an exciting journey for us in Biologics. Hetero's Bevacizumab is the third product in our biologics portfolio, after Darbepoetin alfa and Rituximab. We believe CizumabTM will be a cost-effective treatment option to patients in India."
The product will be manufactured in the company's dedicated state-of-the-art biologics facility based in Hyderabad, India.
Hetero is one of India's leading generic pharmaceutical companies and is one of the world's largest producers of anti-retroviral drugs for the treatment of HIV/AIDS. With more than 20 years of expertise in the pharmaceutical industry, Hetero's strategic business areas include APIs, finished formulations and biosimilars. Hetero also offers custom pharmaceutical services to its partners around the world. The company is recognized for its strengths in Research & Development, manufacturing and commercialization of a wide range of products.
Hetero has more than 25 state-of-the-art manufacturing facilities strategically located worldwide. Majority of our facilities have been successfully audited and approved by various regulatory authorities like US-FDA, EU, TGA - Australia, MCC - South Africa and others. Our portfolio includes more than 200 products, encompassing major therapeutic categories such as HIV/AIDS, oncology, cardiovascular, neurology, hepatitis, etc.
Hetero has a strong global presence in over 120 countries and focuses on making affordable medicines accessible to patients worldwide.
Media Contact: A Jeyasingh Balakrishnan Corporate Communications Hetero Mobile: +91-9989626541/ +91-9833836185 Email: firstname.lastname@example.org
Subscribe to our Free Newsletters!
Merkel cell carcinoma is a rare and a highly aggressive primary skin cancer that grows rapidly and ...
Vitrectomy is a surgical procedure performed to remove a part or whole of the vitreous humor ...
Boosting metabolism is what you might need to pump your weight loss regime. Slow body metabolism ...View All